Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, ...

Image credit Bladder health is often overlooked, although it is critical to our entire well-being. When your bladder do ...

That said, research shows that Botox functions better as a short-term treatment given it cannot cure overactive bladder; the goal, rather, is to help control or lessen symptoms, Wood said. Botox is ...

TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and ...

A recent study published in the New England Journal of Medicine and found no significant survival benefit of extended ...

We randomly assigned, in a 1:1 ratio, patients with localized muscle-invasive bladder cancer of clinical ... protocol-specified quality-control assessment involving 100 randomly selected patients ...

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher ...

The SWOG S1011 trial shows no survival benefit from extended lymphadenectomy in bladder cancer, revealing higher complications and mortality post-surgery.

Older women suffering from urine incontinence can benefit from frequent, low-impact exercise, including yoga, stretching, and ...

This progressive and aggressive type of neuropathy often begins in the feet and gradually travels up the body, eventually weakening the muscles that control breathing. The onset of GBS requires ...

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher ...